TAG:
blood brothers
AmeriPath, SmithKline, Unilab, IMPATH, LabOne, Prudential/SBCL
By Robert Michel | From the Volume V No. 3 – March 2, 1998 Issue
AMERIPATH REPORTS EARNINGS, NEW PURCHASE AmeriPath, Inc. of Riviera Beach, Florida announced its 1997 financial performance. For the year, company revenues totaled $108.4 million. On February 17, the company also disclosed the acquisition of Anatomic Pathology Associates (A…
30-Hospital Lab Contract Inked By Tenet & SBCL
By Robert Michel | From the Volume V No. 1 – January 19, 1998 Issue
CEO SUMMARY: By signing this deal with Tenet, SmithKline Beecham Clinical Laboratories captured one of the largest hospital laboratory management contracts ever offered. The project’s size, scale and far-flung geography make this a daunting challenge, particularly given California’s c…
1997’s Top Ten Lab Stories Predict New Directions
By Robert Michel | From the Volume IV No. 18 – December 29, 1997 Issue
CEO SUMMARY: Events during 1997 reveal that the laboratory industry continues to undergo fundamental change. Yet even amidst the industry’s downsizing, selected laboratory organizations continue to flourish. Here is THE DARK REPORT’s annual look at top stories for the year. A careful …
Quest Announces Major Restructuring for 1998
By Robert Michel | From the Volume IV No. 17 – December 8, 1997 Issue
CEO SUMMARY: Recognizing the reality of laboratory over-capacity in the marketplace, Quest Diagnostics Incorporated intends to align its laboratory capacity with existing specimen volumes. In so doing, it’s taking a progressive step and moving more aggressively than its two national com…
Hitting Financial Bottom
By R. Lewis Dark | From the Volume IV No. 16 – November 17, 1997 Issue
During the last three years, financial news from the clinical laboratory industry has generally been bad. Two things attracted the media’s attention. Multi-million dollar Medicare fraud settlements involving laboratories got widespread notoriety. Financial losses at public laboratories attracted le…
Regional Tox Laboratory Shows Sustained Growth
By Robert Michel | From the Volume IV No. 16 – November 17, 1997 Issue
CEO SUMMARY: Over a three-year period, this regional substance abuse laboratory has shown dramatic growth in revenue and operating profits. Strong leadership combined with good implementation skills fuel this lab’s success. HERE’S ANOTHER QUIET SUCCESS story about a reg…
Quest Diagnostics & SmithKline Release Third Quarter Financials
By Robert Michel | From the Volume IV No. 15 – October 27, 1997 Issue
It appears that 1997 will be kinder to Quest Diagnostics Inc. and SmithKline Beecham Clinical Laboratories (SBCL) than the last three years. Both companies reported improved financial results for third quarter and mixed results for year-to-date. As of press time, …
Innovative Approach Promises Integration of Clinical Lab Data
By Robert Michel | From the Volume IV No. 12 – August 25, 1997 Issue
CEO SUMMARY: Any laboratory executive with several years in the business has confronted the limitations of laboratory information system (LIS) software. For a variety of reasons, LIS software seldom delivers the full range of benefits and cost-effectiveness sought by laboratories. But in …
3 Blood Brothers Differ On Surcharge Strategies
By Robert Michel | From the Volume IV No. 10 – July 14, 1997 Issue
CEO SUMMARY: United we stand, divided we fall. On the issue of laboratory test surcharge repeal in New York, the three national labs took independent positions. Was the clinical industry served by this lack of unanimity? More importantly, do the actions of two of these national laboratori…
Physician Management Companies Exploding, Will Transform Healthcare
By Robert Michel | From the Volume IV No. 10 – July 14, 1997 Issue
CEO SUMMARY: Consolidation and integration of healthcare services will be the dominant trend during the next five years. It happened to commercial laboratories from 1985-95. Widespread hospital consolidation began around 1990 and continues today. Now consolidation is coming to physicians….
CURRENT ISSUE

Volume XXXII, No. 13 – September 15, 2025
The Dark Report examines a new bill that would reform PAMA and avoid reimbursement rate cuts scheduled for January 2026. Clinical laboratory leaders are urged to make their voices heard in Congress. Also, an expert describes how labs can fix pre-analytical errors and avoid disaster.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized